Pressure Monitoring for Compartment Syndrome
(VA-ECMO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new methods to diagnose acute compartment syndrome (ACS), a condition where a limb loses blood flow, in patients on ECMO (a machine that aids breathing and heart function). ACS is difficult to detect in these patients because sedation prevents them from reporting symptoms. The trial compares three methods: usual care, usual care plus a new device called MY01 for continuous compartment pressure monitoring, and usual care plus an older continuous monitoring method. Sedated patients on ECMO, especially those without prior limb blood flow issues before ECMO, might be suitable for this trial. The goal is to identify the best way to quickly and accurately diagnose ACS, potentially saving more limbs.
As an unphased trial, this study explores innovative diagnostic methods, offering participants a chance to contribute to potentially life-saving advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these methods for diagnosing ACS are safe?
Research shows that the MY01 Continuous Compartment Pressure Monitor gently measures pressure inside muscles in real time. It helps doctors quickly and accurately diagnose acute compartment syndrome, a condition where muscle pressure becomes dangerously high, allowing for faster treatment. The device is likely safe and well-tolerated.
Studies indicate that the 14-gauge slit catheter monitor effectively tracks pressure with high accuracy. However, it requires inserting a fluid-filled tube into the muscle, making it more invasive than the MY01 device. Both methods are generally used in medical settings to catch problems early and prevent serious complications.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores advanced techniques for monitoring compartment syndrome, a serious condition that can cause muscle and nerve damage. Unlike the standard practice, which involves periodic checks, these experimental approaches offer continuous monitoring through innovative devices. The MY01 device and the 14-gauge slit catheter provide real-time pressure data, potentially catching dangerous changes earlier. By integrating these methods with standard care, the trial aims to improve patient outcomes through more timely and accurate diagnosis.
What evidence suggests that this trial's methods for diagnosing acute compartment syndrome could be effective?
Research has shown that the MY01 Continuous Compartment Pressure Monitor, which participants in this trial may receive, accurately tracks pressure changes in muscle areas. This device enables ongoing pressure checks, potentially improving the diagnosis of acute compartment syndrome (ACS). Early findings suggest that continuous monitoring could lead to quicker surgeries and better chances of saving limbs compared to single pressure checks.
The trial will also study the 14-gauge slit catheter, which has proven effective in tracking pressure over time, with a high ability to correctly identify those with the condition (94% sensitivity) and those without it (98% specificity). Both the MY01 device and the 14-gauge slit catheter are being evaluated in this trial for their potential to improve ACS diagnosis, providing more consistent and accurate readings than traditional methods.12346Who Is on the Research Team?
Babar Shafiq, MD, MSPT
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 on VA-ECMO who are sedated. It's designed to help those at risk of acute compartment syndrome, a condition where limbs lose blood flow often due to ECMO itself.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive monitoring for compartment syndrome using different methods: Standard of Care, MY01 device, and 14-gauge slit catheter.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including outcomes such as amputation and survival.
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Compartment Pressure Monitoring
Continuous Compartment Pressure Monitoring is already approved in Canada for the following indications:
- Diagnosis of Acute Compartment Syndrome in VA-ECMO patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor